RecruitingPhase 3NCT03368092

Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Strasbourg, France
Intervention
Dornase Alfa Inhalant Solution [Pulmozyme](drug)
Enrollment
500 enrolled
Eligibility
18 years · All sexes
Timeline
20192027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03368092 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials